Safety, Efficacy, and Pharmacokinetics of Combination SARS-CoV-2 Neutralizing Monoclonal Antibodies BMS-986414 (C135-LS) and BMS-986413 (C144-LS) Administered Subcutaneously in Non-Hospitalized Persons with COVID-19 in a Phase 2 TrialResearch Article Published on 2024-05-062024-09-05 Journal: Pathogens and Immunity [Category] update2024, [키워드] COVID-19 monoclonal antibodies outpatient treatment SARS-CoV-2 Subcutaneous [DOI] 10.20411/pai.v9i1.660 PMC 바로가기 [Article Type] Research Article
Early 3-day course of remdesivir in vaccinated outpatients with SARS-CoV-2 infection. A success storyArticle Published on 2022-12-012023-07-10 Journal: Journal of chemotherapy (Florence, Italy) [Category] COVID19(2023년), [키워드] antiviral agent COVID-19 outpatient treatment Remdesivir SARS-CoV-2 [DOI] 10.1080/1120009X.2022.2099693